blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1932525

EP1932525 - SKIN-CARE PREPARATIONS CONTAINING MUPIROCIN AND BETAMETHASONE DIPROPIONATE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.09.2011
Database last updated on 30.10.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Laboratorios Dermatologicos Darier, S.A. de C.V.
Insurgentes Sur 3579 Torre 3, Piso 8 Col. Tlalpan Centro
Mexico D.F., C.P. 14000 / MX
[2010/47]
Former [2010/44]For all designated states
Laboratories Dermatologicos Darier, S.A. de C.V.
Insurgentes Sur 3579 Torre 3, Piso 8 Col. Tlalpan Centro
Mexico D.F., C.P. 14000 / MX
Former [2008/25]For all designated states
Ahumada Ayala, Fernando
Av. Insurgentes sur No. 3579, Torre 3 Piso 8, Locales 801 al 804 Colonia Tlalpan
C.P. 14020 Distrito Federal / MX
Inventor(s)01 / SOTO GUTIÉRREZ Manuel
Hamburgo Nr. 260 Col. Juárez
C.P. 06600 México, D.F. / MX
 [2008/25]
Representative(s)Hatzmann, Martin, et al
V.O.
Johan de Wittlaan 7
2517 JR Den Haag / NL
[N/P]
Former [2008/25]Hatzmann, Martin, et al
VEREENIGDE Johan de Wittlaan 7
2517 JR Den Haag / NL
Application number, filing date05787388.728.09.2005
[2008/25]
WO2005MX00084
Priority number, dateMX2005PA0938102.09.2005         Original published format: MX PA05009381
[2008/25]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007027077
Date:08.03.2007
Language:EN
[2007/10]
Type: A1 Application with search report 
No.:EP1932525
Date:18.06.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2007 takes the place of the publication of the European patent application.
[2008/25]
Type: B1 Patent specification 
No.:EP1932525
Date:24.11.2010
Language:EN
[2010/47]
Search report(s)International search report - published on:ES08.03.2007
(Supplementary) European search report - dispatched on:EP27.03.2009
ClassificationIPC:A61K31/351, A61K31/573, A61K47/10, A61K47/44
[2010/11]
CPC:
A61K31/351 (EP,US); A61K31/573 (EP,US); A61P17/00 (EP)
C-Set:
A61K31/351, A61K2300/00 (EP,US);
A61K31/573, A61K2300/00 (US,EP)
Former IPC [2008/25]A61K31/351, A61K31/573
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/25]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:HAUTPFLEGEZUBEREITUNGEN WELCHE MUPIROCIN UND BETAMETHASON-DIPROPIONAT ENTHALTEN[2010/41]
English:SKIN-CARE PREPARATIONS CONTAINING MUPIROCIN AND BETAMETHASONE DIPROPIONATE[2008/25]
French:PREPARATIONS DE SOIN CUTANE CONTENANT DE LA MUPIROCINE ET DU DIPROPIONATE DE BETAMETHASONE[2008/25]
Former [2008/25]HAUTPFLEGEZUBEREITUNGEN MIT MUPIROCIN UND BETAMETHASON-DIPROPIONAT
Entry into regional phase31.03.2008Translation filed 
31.03.2008National basic fee paid 
31.03.2008Search fee paid 
31.03.2008Designation fee(s) paid 
31.03.2008Examination fee paid 
Examination procedure31.03.2008Examination requested  [2008/25]
30.07.2009Despatch of a communication from the examining division (Time limit: M06)
01.02.2010Reply to a communication from the examining division
21.04.2010Communication of intention to grant the patent
23.08.2010Fee for grant paid
23.08.2010Fee for publishing/printing paid
Opposition(s)25.08.2011No opposition filed within time limit [2011/44]
Fees paidRenewal fee
31.03.2008Renewal fee patent year 03
15.09.2008Renewal fee patent year 04
15.09.2009Renewal fee patent year 05
14.09.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.11.2010
CY24.11.2010
CZ24.11.2010
DK24.11.2010
EE24.11.2010
FI24.11.2010
HU24.11.2010
LT24.11.2010
LV24.11.2010
NL24.11.2010
PL24.11.2010
RO24.11.2010
SE24.11.2010
SI24.11.2010
SK24.11.2010
TR24.11.2010
BG24.02.2011
GR25.02.2011
IS24.03.2011
PT24.03.2011
[2013/45]
Former [2013/44]AT24.11.2010
CY24.11.2010
CZ24.11.2010
DK24.11.2010
EE24.11.2010
FI24.11.2010
LT24.11.2010
LV24.11.2010
NL24.11.2010
PL24.11.2010
RO24.11.2010
SE24.11.2010
SI24.11.2010
SK24.11.2010
TR24.11.2010
BG24.02.2011
GR25.02.2011
IS24.03.2011
PT24.03.2011
Former [2011/38]AT24.11.2010
CY24.11.2010
CZ24.11.2010
DK24.11.2010
EE24.11.2010
FI24.11.2010
LT24.11.2010
LV24.11.2010
NL24.11.2010
PL24.11.2010
RO24.11.2010
SE24.11.2010
SI24.11.2010
SK24.11.2010
BG24.02.2011
GR25.02.2011
IS24.03.2011
PT24.03.2011
Former [2011/29]AT24.11.2010
CY24.11.2010
FI24.11.2010
LT24.11.2010
LV24.11.2010
NL24.11.2010
SE24.11.2010
SI24.11.2010
BG24.02.2011
GR25.02.2011
IS24.03.2011
PT24.03.2011
Former [2011/23]FI24.11.2010
LT24.11.2010
LV24.11.2010
IS24.03.2011
Former [2011/19]LT24.11.2010
Cited inInternational search[A]EP0231621  (BEECHAM GROUP PLC [GB]);
 [A]ES2165723T  (AGIS IND 1983 LTD);
 [A]  - MOURYA V.K. ET AL., "Evaluation of mupirocin in Mupirocin Ointment and Mupirocin with Betamethasone Dipropionate Ointment", EASTERN PHARMACIST, (200001), vol. 43, no. 505, pages 143 - 145, XP008078376
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.